The COVID-19 pandemic showed many problems in supply chains all over the world. A McKinsey study found that 93% of supply chain leaders in many industries, including healthcare, said they needed to make their supply chains more flexible, quick, and strong after the pandemic. This shows how serious the problem was and how fast action was needed.
One big issue was that traditional global supply chains were not flexible. Healthcare groups faced sudden high demand for things like personal protective equipment (PPE), ventilators, medicines, and testing supplies. At the same time, lockdowns caused problems with getting supplies, leading to serious shortages. Hospitals had a hard time buying these items and often had to pay extra in emergencies, which made budgets tight.
The pandemic also showed that many healthcare providers depended a lot on a small number of suppliers, often from other countries. This was risky because relying on only one or few suppliers far away can cause big problems during worldwide crises. For example, only 2% of companies could find risks beyond their main suppliers. These extra suppliers, like those making important parts such as semiconductors for medical tools, were hard to track. Without knowing about these hidden risks, companies could not manage problems well.
The healthcare sector acted more strongly than many other industries to fix their supply chains. About 60% of healthcare groups moved to regional supply chains. This means they started buying supplies closer to where they were needed, within the US or nearby regions. The goal was to rely less on shipments that had to travel long distances and might be stopped due to travel bans or closed ports.
Also, about 33% of healthcare companies moved their production sites nearer to where the demand was. These changes helped reduce risks and made products arrive faster and more reliably during emergencies. Compared to healthcare, industries like car making and aerospace only made these changes about 22% of the time.
Healthcare groups also improved their risk management. After the pandemic, 95% said they had formal systems to find weak spots and prepare backup plans for buying and stocking supplies. Even with these improvements, it is still hard to watch risks beyond the closest suppliers.
Making supply chains strong means they can handle and adjust to problems without breaking. Some key strategies for healthcare in the US include:
These strategies work, but there are challenges:
Environmental, Social, and Governance (ESG) policies have become important for stable supply chains. A recent study looked at how geopolitical events, like the Russian-Ukrainian conflict, affected companies focusing on ESG. Companies that actively worked on environmental and social responsibilities handled disruptions better.
In the US healthcare sector, adding ESG ideas to supply chain management can bring benefits in the long run. Sustainable buying, reducing waste, and clear supplier relationships help lower future risks and keep the supply chain steady.
The research also showed that companies with good ESG practices faced fewer financial problems during global disruptions. Investors and partners preferred businesses with strong resilience plans.
Technology helps solve some supply chain problems in US healthcare. Artificial intelligence (AI) and workflow automation improve how things get done, making processes faster, more correct, and responsive.
AI uses large data to better predict how much medical supply is needed. Compared to older methods, AI looks at many factors like number of patients, seasons, disease data, and how well suppliers perform. This leads to better planning and less chance of having too much or too little stock.
AI can check real-time data from suppliers, stock systems, and outside sources like weather or politics. It can warn managers about risks early. This helps healthcare teams act ahead of time rather than waiting for problems to happen.
Workflow automation makes routine tasks easier, like making orders and tracking deliveries. AI systems can order supplies automatically when stock gets low, so items are replaced quickly.
Automation also shows clear views on stock status, supplier delivery times, and checks for compliance. This lowers human mistakes and lets staff focus on planning instead of data entry.
Good communication with suppliers and internal teams is very important during crises. Simbo AI, a company that offers AI-based phone automation and answering services, helps healthcare cut down on administrative work. Automating calls and questions about orders and supplies speeds up replies and keeps information correct.
This technology is useful for clinics with few administrative workers. It helps coordinate well with suppliers and teams and cuts down delays from bad communication.
Using AI with supply chain risk management helps make better choices. AI models look at supplier risks by checking credit scores, delivery records, and political situations. Together with human review, this helps healthcare groups change buying plans quickly when needed.
COVID-19 showed medical leaders in the US how to improve their supply chains. Focusing on buying locally, using many suppliers, digital tools, and AI automation can make supply chains stronger. But they need to plan budgets, train staff, and work together across buying, clinical, and IT teams.
Administrators should start formal risk management that includes checking beyond just main suppliers. Investing in digital skills training can fix the lack of supply chain experts. IT managers play a key role in setting up AI and automation tools that keep supply chain work smooth.
Adding ESG policies can help medical groups build better supplier relations and stronger supply chains. Since healthcare faces ongoing challenges like pandemics, political problems, and climate issues, having strong supply chains supported by advanced technology is needed to keep patient care steady.
By knowing how COVID-19 affected global supply chains and using what was learned, healthcare providers in the US can build supply chains that hold up better to future problems. Methods like local sourcing, good inventory management, ESG policies, and new AI tools form a broad plan to fix supply chain problems seen in recent crises.
The pandemic highlighted vulnerabilities, such as a lack of flexibility and resilience in global supply chains, causing firms to rethink their configurations and operations.
93 percent of respondents in a survey indicated intentions to enhance flexibility, agility, and resilience in their supply chains.
Healthcare players adopted a broader range of resilience measures, with 60% regionalizing their supply chains and 33% moving production closer to end markets.
Companies emphasized proactive monitoring of supplier risks, with 95% implementing formal risk management processes post-pandemic.
Organizations with advanced analytics capabilities reported better supply chain planning performance, with successful firms being 2.5 times more likely to use these tools.
An overwhelming majority reported investing in digital technologies, with most planning increased investments for the upcoming years.
The skills gap is widening, with only 1% of companies reporting sufficient in-house digital talent, making it a barrier to accelerated digitization.
Chemicals and commodity players exhibited the smallest overall changes in their supply-chain footprints, largely due to their asset-intensive nature.
Many companies lack visibility into their supply chains beyond tier-one suppliers, with only 2% able to assess risks in third-tier and beyond suppliers.
Almost 90% of respondents expect to pursue some degree of regionalization in the next three years, with healthcare and engineering sectors particularly focused on this strategy.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
